DSW sues Ottobock over Russia disclosures: EUR 83.00 target for Ottobock stock
Published on 10/15/2026 at 11:52 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSRussia case and analyst view
- DSW challenged Ottobock disclosures on October 7, 2026, citing Russia exposure of 10 percent of revenue.
- Jefferies retained its EUR 83.00 target and Buy rating on September 15, 2026.
- Ottobock stock traded at EUR 53.60 at 11:43 a.m. CEST at Lang & Schwarz on October 15, 2026.
Ottobock stock (ISIN DE000BCK2223) was trading at EUR 53.60 at Lang & Schwarz on October 15, 2026 at 11:43 a.m. CEST. The latest company-specific catalyst is a Russia-related lawsuit reported on October 7, 2026, while Jefferies had retained an EUR 83.00 target on September 15, 2026.
Russia lawsuit puts disclosures under scrutiny
According to finanzen.ch on October 7, 2026, the Deutsche Schutzgemeinschaft für Wertpapierbesitz challenged Ottobock's disclosures about its Russian business. The report said Russia still represented 10 percent of revenue, making the prospectus and investor communication the central issue.
Ottobock's response is material for the stock because the dispute concerns information provided around its public listing. The legal question is separate from operating performance, but it adds a governance and disclosure risk to the investment case.
What does the EUR 83.00 target imply?
Finanznachrichten reported on September 15, 2026 that Jefferies kept its Buy rating and EUR 83.00 target. The target lies 54.85 percent above the Lang & Schwarz price, calculated from EUR 53.60, although the two figures carry different dates.
Three dated Ottobock developments
On August 13, 2026, Ottobock published its half-year financial report, while its investor page also lists adjusted group profit of EUR 13.5 million for fiscal year 2025. On September 15, 2026, the company announced that its Cranial Technologies IP litigation had been settled and disclosed more than 2,600 patents and patent applications. On October 7, 2026, the Russia disclosure lawsuit became the latest dated event, with 10 percent of revenue cited in the report.
Upcoming dates for investors
Ottobock's investor-relations calendar schedules its third-quarter interim statement for November 12, 2026. The calendar also lists the BNP Paribas MidCap CEO Conference on November 16, 2026, giving investors two dated milestones for the next phase of company communication.
Stock price and company profile
The current quote places the stock EUR 29.40 below Jefferies' EUR 83.00 target. That gap frames the market's valuation debate, while the Russia case keeps disclosure quality alongside revenue growth and margins as an investor concern.
Ottobock was trading at EUR 53.60 at Lang & Schwarz on October 15, 2026 at 11:43 a.m. CEST.
Ottobock stock key facts
- Company: Ottobock SE & Co. KGaA
- ISIN: DE000BCK2223
- WKN: BCK222
- Ticker: OBCK
- Primary exchange: Xetra
- Price Lang & Schwarz (as of October 15, 2026, 11:43 a.m. CEST): EUR 53.60
- Sector / Industry: Health care / Medical technology
- Index membership: TecDAX
Market context: Market report DAX.
